Markets
markets

Abbott stock dives after company gives gloomy outlook, despite earnings beat

Abbott Laboratories fell in early trading after it lowered its full-year outlook, despite posting second-quarter earnings that beat Wall Street estimates.

The company now expects to report full-year earnings per share between $5.10 and $5.20, down from its earlier guidance of $5.05 to $5.25 a share. Shares fell 6% in premarket trading.

The company reported second-quarter earnings of $1.26 a share, edging just above the $1.25 that analysts polled by FactSet were expecting. It also reported $11.1 billion in revenue, in line with expectations.

More Markets

See all Markets

Latest Stories

Sherwood Media, LLC produces fresh and unique perspectives on topical financial news and is a fully owned subsidiary of Robinhood Markets, Inc., and any views expressed here do not necessarily reflect the views of any other Robinhood affiliate, including Robinhood Markets, Inc., Robinhood Financial LLC, Robinhood Securities, LLC, Robinhood Crypto, LLC, or Robinhood Money, LLC.